title: Calcitonin gene methylation in chronic myeloproliferative disorders.
abstract: Alterations in DNA methylation appear to be an integral part of the malignant transformation. For example, the p15 region of chromosome 11 with multiple genes related to cell growth regulation exhibits different methylation patterns in the 5' area of the calcitonin A gene in healthy bone marrow cells, and in leukemic cell populations. In this work the methylation status of the 5' area of the calcitonin gene in myeloproliferative disorders (MPD) other than chronic myeloid leukemia (CML) is studied. A total number of 37 patients with polycythemia vera, essential thrombocythemia, or myelofibrosis were studied. A control group of 18 healthy persons and patients with reactive hematologic changes was included. The DNA isolated from peripheral blood or bone marrow cells was digested with the methylation-sensitive HpaII restriction enzyme. A Southern blot was hybridized with a 1.7 kb probe specific to the 5' area of the calcitonin gene. The result was visualized autoradiographically and analyzed with a densitometer. The results have been expressed as ratios between the abnormal and normal autoradiography band intensities, referred to as the calc-value or CALC. An increase in the calc-value signifies increasing methylation. In the control group the calc-value had a mean of 0.274. The myelofibrosis patients exhibited very strong hypermethylation in the calcitonin gene 5' area, with a mean calc-value of 11.1 (median 2.6). The polycythemia vera patients showed considerable variation in their methylation status, with a mean value of 1.52. The essential thrombocythemia patients exhibited weak hypermethylation, with a mean calc-value of 0.58. A correlation between karyotypic abnormalities and hypermethylation was observed. Complicated forms of MPD exhibited higher levels of methylation than the uncomplicated disease forms.
authors.affiliation: Department of Clinical Chemistry, University of Helsinki, Finland.
authors.forename: J
authors.initials: J
authors.lastname: Ihalainen
authors.forename: E
authors.initials: E
authors.lastname: Juvonen
authors.forename: E R
authors.initials: ER
authors.lastname: Savolainen
authors.forename: T
authors.initials: T
authors.lastname: Ruutu
authors.forename: A
authors.initials: A
authors.lastname: Palotie
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002116:Calcitonin / Q000235:genetics*; D002908:Chronic Disease; D004247:DNA / Q000378:metabolism; D005260:Female; D005796:Genes; D006801:Humans; D008297:Male; D008745:Methylation; D008875:Middle Aged; D009196:Myeloproliferative Disorders / Q000235:genetics* / Q000378:metabolism; D011087:Polycythemia Vera / Q000235:genetics; D055728:Primary Myelofibrosis / Q000235:genetics; D013920:Thrombocythemia, Essential / Q000235:genetics
chemical_list: D002116:Calcitonin; D004247:DNA